MedPath
NMPA Approval

Sodium Nitroprusside Injection

国药准字H20223226

April 12, 2022

Drug Information

硝普钠注射液

注射剂

2ml:50mg[按Na₂[Fe(CN)₅NO] ·2H₂O计]

化学药品

April 12, 2022

Company Information

Applicant Company

海口市美兰区桂林洋经济开发区

Manufacturing Company

海口市美兰区桂林洋经济开发区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

硝普钠注射液 - NMPA 批准文号 | MedPath